Jiangsu GDK Biotechnology Co Ltd Cash Flow Reinvestment Rate

Latest as of December 2023: 17.95x

Jiangsu GDK Biotechnology Co Ltd cash flow reinvestment rate. Jiangsu GDK Biotechnology Co Ltd (688670) has a Cash Flow Reinvestment Rate of 17.95x as of December 2023, reinvesting CN¥407.60 Million (capex CN¥35.83 Million plus investments CN¥-371.77 Million) from operating cash flow of CN¥22.70 Million. See Jiangsu GDK Biotechnology Co Ltd (688670) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

17.95x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥407.60 Million
Capex + Investments

Operating Cash Flow

CN¥22.70 Million
CNY

Capital Expenditures

CN¥35.83 Million
CNY

Cash Flow Reinvestment Rate of Jiangsu GDK Biotechnology Co Ltd (2020–2023)

Cash flow reinvestment rate of Jiangsu GDK Biotechnology Co Ltd from 2020 to 2023. Historical reinvestment intensity for Jiangsu GDK Biotechnology Co Ltd across 4 annual periods. Explore debt repayment capacity of Jiangsu GDK Biotechnology Co Ltd to assess how comfortably operating cash covers total debt obligations.

Jiangsu GDK Biotechnology Co Ltd Cash Flow Reinvestment Rate by Year (2020–2023)

Jiangsu GDK Biotechnology Co Ltd cash flow reinvestment rate by year from 2020 to 2023. Year-by-year capital reinvestment analysis for Jiangsu GDK Biotechnology Co Ltd. For the full cash flow conversion analysis, see Jiangsu GDK Biotechnology Co Ltd cash flow conversion.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2023 0.81x CN¥65.30 Million CN¥80.90 Million CN¥54.00 Million ▼ -88.9%
2022 7.28x CN¥280.87 Million CN¥38.60 Million CN¥168.18 Million ▼ -45.3%
2021 13.31x CN¥1.38 Billion CN¥103.93 Million CN¥386.39 Million ▲ +1199.5%
2020 1.02x CN¥112.07 Million CN¥109.46 Million CN¥40.81 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow